China’s NRDL includes Akeso’s two bispecific antibody drugs, cadonilimab & ivonescimab: Hong Kong Friday, November 29, 2024, 10:00 Hrs [IST] Akeso, Inc., a leading biopharmace ...
AI and digital tech reshape a new era in drug discovery and career avenues: Dr. Kunal Gokhale: Shardul Nautiyal, Mumbai Friday, November 29, 2024, 08:00 Hrs [IST] The pharmaceutic ...
Parliamentary panel to delve into price rise of medicines, need for regulatory reforms among others: Gireesh Babu, New Delhi Friday, November 29, 2024, 08:00 Hrs [IST] The Departm ...
DoP rejects review application of Cipla against price fixation of antiviral drug acyclovir 800 mg: Gireesh Babu, New Delhi Friday, November 29, 2024, 08:00 Hrs [IST] The Departmen ...
UPF assures of 18 guarantees in its manifesto for election to WB SPC: Peethaambaran Kunnathoor, Chennai Friday, November 29, 2024, 08:00 Hrs [IST] Ahead of the upcoming state phar ...
Evidence-based clinical studies a cornerstone for advances in surgical technologies: Rohit Mahajan: Nandita Vijayasimha, Bengaluru Friday, November 29, 2024, 08:00 Hrs [IST] Evide ...
SunAct inks deal with Malaysian firm Abgentil to introduce cutting-edge cancer treatment for solid state tumours in India: ...
OPPI Annual Summit presents the roadmap on becoming the pharma powerhouse to the world: Our Bureau, Mumbai Thursday, November ...
Marvel Biosciences announces new additional data from Rett syndrome study; plans to discuss results with US FDA: Calgary, Alberta Thursday, November 28, 2024, 18:00 Hrs [IST] Calg ...
PTC Therapeutics’ phase 2 CardinALS study of utreloxastat in ALS patients fails to meet primary endpoint: Warren, New Jersey Thursday, November 28, 2024, 15:00 Hrs [IST] PTC The ...
BCG-OPPI Report highlights Indian healthcare market to unlock disruptive growth: Our Bureau, Bengaluru Thursday, November 28, 2024, 15:15 Hrs [IST] Organisation of Pharmaceutical ...
Fedo.ai with Electronic Village to empower health benchmarking across the GCC Region: Our Bureau, Bengaluru Thursday, November 28, 2024, 14:45 Hrs [IST] Fedo.ai, an AI-driven plat ...